Repository logo
 
Publication

Defining basic rules for hardening influenza A virus liquid condensates

dc.contributor.authorEtibor, Temitope Akhigbe
dc.contributor.authorVale-Costa, Silvia
dc.contributor.authorSridharan, Sindhuja
dc.contributor.authorBrás, Daniela
dc.contributor.authorBecher, Isabelle
dc.contributor.authorMello, Victor Hugo
dc.contributor.authorFerreira, Filipe
dc.contributor.authorAlenquer, Marta
dc.contributor.authorSavitski, Mikhail M
dc.contributor.authorAmorim, Maria-João
dc.date.accessioned2023-04-19T13:53:33Z
dc.date.available2023-04-19T13:53:33Z
dc.date.issued2023-04-04
dc.description.abstractIn biological systems, liquid and solid-like biomolecular condensates may contain the same molecules but their behaviour, including movement, elasticity and viscosity, is different on account of distinct physicochemical properties. As such, it is known that phase transitions affect the function of biological condensates and that material properties can be tuned by several factors including temperature, concentration and valency. It is, however, unclear if some factors are more efficient than others at regulating their behaviour. Viral infections are good systems to address this question as they form condensates de novo as part of their replication programmes. Here, we used influenza A virus liquid cytosolic condensates, A.K.A viral inclusions, to provide a proof of concept that liquid condensate hardening via changes in the valency of its components is more efficient than altering their concentration or the temperature of the cell. Liquid IAV inclusions may be hardened by targeting vRNP interactions via the known NP oligomerizing molecule, nucleozin, both in vitro and in vivo without affecting host proteome abundance nor solubility. This study is a starting point for understanding how to pharmacologically modulate the material properties of IAV inclusions and may offer opportunities for alternative antiviral strategies.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.7554/elife.85182pt_PT
dc.identifier.eid85158043945
dc.identifier.issn2050-084X
dc.identifier.pmid37013374
dc.identifier.urihttp://hdl.handle.net/10400.14/40889
dc.identifier.wos000981701500001
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.titleDefining basic rules for hardening influenza A virus liquid condensatespt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleeLifept_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
66978215.pdf
Size:
16.13 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.44 KB
Format:
Item-specific license agreed upon to submission
Description: